Delivery Order SPE2DR25D1103-SPE2DR26FE140
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,408.43 for TALTZ 80 MG/ML AutoInjector on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,055.05 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product...
- The Defense Logistics Agency awarded a $1,749.70 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, competitively awarded contract with performance completion scheduled for December 12, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $4,580.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjectors, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be supplied to the place of...
- The Defense Logistics Agency awarded a delivery order valued at $3,499.42 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on November 12, 2025, with completion scheduled for November 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,753.04 to AmerisourceBergen Drug Corp on June 4, 2025, for TALTZ 80 mg/ml autoinjector units. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award of this pharmaceutical product through the federal procurement process. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 5, 2025. This...
- The Defense Logistics Agency (DLA) awarded a $31,833.56 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical products, with an ultimate completion date of July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a $18,151.80 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector medication, with a completion date of September 8, 2025. The contract was competitively awarded on September 5, 2025, with no set-aside designation, utilizing firm fixed-price terms. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical supplies, valued at $12,756.05 under a firm fixed price contract structure. This non-competitive delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a direct fulfillment action against AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE140Delivery Order
The Defense Logistics Agency (DLA) awarded a $4,188.00 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for TALTZ 80 mg/ml autoinjectors, with completion scheduled for December 2, 2025. This non-competitive delivery order utilizes a firm fixed price structure and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor and critical vendor for federal medical procurement serving military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and provides global pharmaceutical support across multiple therapeutic domains. TALTZ (ixekizumab) is a biologic medication used primarily for the treatment of autoimmune and inflammatory conditions. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling medical supply needs through open competition, with delivery orders ranging significantly in value to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 11/30/25 |